Biotechnology - , ,
Corregene have established a cutting-edge platform for T-cell receptor identification and affinity optimization. Based on this platform, we are able to develop affinity-optimized-TCR against shared tumor antigens, like MAGE-A1, NY-ESO-1 and AFP. We are dedicated to provide late-stage cancer patients with effective treatments by engineering patients' T cells with optimized TCR.
Apache Coyote v1.1
Apache